Standard Biotools (LAB) Total Debt (QoQ) (2011 - 2024)
Standard Biotools (LAB) Total Debt (QoQ) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.24% |
| Jun 30, 2024 | 0.23% |
| Mar 31, 2024 | -5.67% |
| Dec 31, 2023 | -12.49% |
| Sep 30, 2023 | -7.48% |
| Jun 30, 2023 | 0.56% |
| Mar 31, 2023 | 0.55% |
| Dec 31, 2022 | 0.57% |
| Sep 30, 2022 | 0.56% |
| Jun 30, 2022 | 0.55% |
| Mar 31, 2022 | 0.57% |
| Dec 31, 2021 | 0.49% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | -70.44% |
| Mar 31, 2012 | -37.43% |
| Dec 31, 2011 | -12.53% |
| Sep 30, 2011 | -10.89% |
| Jun 30, 2011 | 364.50% |
| Mar 31, 2011 | -80.95% |